Adaptix announces CEO transition Our medical imaging technology associate company Adaptix Limited announced today the departure of Chief Executive Officer, Mark Evans. He will be succeeded by interim CEO, Sarah Small and Willem Baralt, the current Chair of the Board, who will be more actively involved in the company on a day-to-day basis. Willem stated…
Adaptix appoints Willem Baralt as new Chairman Avingtrans PLC (AIM: AVG) announces that further to the statement made on 14 December 2022, Adaptix, the Oxford based emerging MedTech Company, has appointed Willem Baralt as its new Chairman. Willem, previously of Quanta Dialysis Technologies, will succeed Steve McQuillan (CEO of Avingtrans), who was appointed to the…
Adaptix secures 510(k) clearance from FDA We are pleased to announce that medical imaging technology associate company Adaptix Limited (Adaptix) has received 510(k) clearance from the U.S. Food and Drug Administration for its first orthopaedic medical imaging product. In 2021, Avingtrans invested £4m in Adaptix, for an 11.9% stake in the business and in December…
Additional Investment in Magnetica We are pleased to announce that shareholders of Magnetica have approved an increase to Avingtrans’ ownership as part of a capital raising. The Board of Magnetica has made the following announcement: Following an Extraordinary General Meeting of the shareholders of Magnetica on 16 January 2023, a resolution in relation to the capital…
Ormandy completes double acquisition Our subsidiary, Ormandy Rycroft Engineering has completed the acquisition of Heating Ventilation and Air Conditioning (HVAC) solutions provider HRS Hevac Ltd (Hevac) and plates and gaskets supplier HeatExchangerSpares.com (HES) from Canadian heat exchanger manufacturer Exchanger Industries Ltd (EIL). HES’s site in Watford (UK) will continue operations while employees from its…
Steve McQuillan appointed as Chairman of Adaptix Avingtrans CEO, Steve McQuillan, has been appointed as the non-executive Chairman of emerging MedTech business, Adaptix, based in Oxford, UK. In parallel, Avingtrans is investing a further £2m in Adaptix, by means of a Convertible Loan Note. In 2021, Avingtrans invested £4m in Adaptix, for an 11.9% stake…
Bolton’s Booth Industries celebrates double award win We are pleased to announce, our subsidiary, Booth Industries, has won the SME of the Year and Business Growth awards at this year’s Make UK Manufacturing Regional Awards. The Make UK Manufacturing Awards celebrate British manufacturing excellence and recognise outstanding people from the industry who have delivered innovative…
Adaptix Submits US Regulatory Clearance for Transformational Diagnostic Product Our partner company, Adaptix has submitted a 510(k) application to the U.S. Food and Drug Administration for its first medical imaging product (‘NeXt 3D-Ortho’), allowing the company to begin marketing its Point-of-Care 3D orthopedic system in the United States. Adaptix, based at Oxford University Science Park,…
Hayward Tyler Inc. Secures Advanced Nuclear Contract Worth $1.1m Our subsidiary, Hayward Tyler Inc. is pleased to announce it has secured a contract extension for the continued development of molten salt pumps under the Advanced Reactor Demonstration Program valued at US $1.1m. This recent contract extends the program value beyond $2.5 million since June 2021. Jeff…
Hayward Tyler Inc. secures two nuclear contracts worth $7m We are pleased to announce our subsidiary, Hayward Tyler Inc., has secured two new nuclear contracts worth a total of US $7m, to be completed before June 2023, from a South Korean customer Korea Hydro & Nuclear Power. These contracts are to provide critical nuclear safety…